| License: Creative Commons Attribution Non-commercial 4.0 PDF - Published Version (365kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-442064
- DOI to cite this document:
- 10.5283/epub.44206
Abstract
Introduction Objective of the ‘German hyperthermic intrathoracic chemotherapy (HITOC) study’ is to evaluate the HITOC as additional treatment after surgical cytoreduction for malignant pleural tumours. Even though HITOC is applied with increasing frequency, there is no standardised therapy protocol concerning the technique of HITOC, the selection as well as dosage of chemotherapeutic agents and ...
Owner only: item control page